BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1510397)

  • 1. Intracellular activity of zidovudine (3'-azido-3'-deoxythymidine, AZT) against Salmonella typhimurium in the macrophage cell line J774-2.
    Herrmann JL; Lagrange PH
    Antimicrob Agents Chemother; 1992 May; 36(5):1081-5. PubMed ID: 1510397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antimicrobial properties of azidothymidine (AZT).
    Monno R; Marcuccio L; Valenza MA; Leone E; Bitetto C; Larocca A; Maggi P; Quarto M
    Acta Microbiol Immunol Hung; 1997; 44(2):165-71. PubMed ID: 9330665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U).
    Elwell LP; Ferone R; Freeman GA; Fyfe JA; Hill JA; Ray PH; Richards CA; Singer SC; Knick VB; Rideout JL
    Antimicrob Agents Chemother; 1987 Feb; 31(2):274-80. PubMed ID: 3551832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
    Bhalla K; Birkhofer M; Grant S; Graham G
    Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
    Richman DD
    Am J Med; 1990 May; 88(5B):8S-10S. PubMed ID: 2186629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditions required for the antibacterial activity of zidovudine.
    Lewin CS; Amyes SG
    Eur J Clin Microbiol Infect Dis; 1989 Aug; 8(8):737-41. PubMed ID: 2506045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental and clinical studies on aztreonam in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1985 Nov; 38(11):3273-84. PubMed ID: 4094059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of 3'-azido-3'-deoxythymidine (AZT) on normal human polymorphonuclear cell and monocyte-macrophage functional capacities.
    De Simone C; Maffione AB; Calvello R; Nacci C; Sciannameo G; Greco B; Caradonna L; Pece S; Antonaci S; Jirillo E
    Immunopharmacol Immunotoxicol; 1996 May; 18(2):161-78. PubMed ID: 8771365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of zidovudine alone and in combination with ciprofloxacin against Salmonella and Escherichia coli.
    Mascellino MT; Iona E; Iegri F; De Gregoris P; Farinelli S
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):23-8. PubMed ID: 8364519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.
    Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral activity and cytotoxicity of novel zidovudine (AZT) derivatives and the relation to their chemical structure.
    Turk G; Moroni G; Pampuro S; Briñón MC; Salomón H
    Int J Antimicrob Agents; 2002 Oct; 20(4):282-8. PubMed ID: 12385685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the SOS response on the activity of 4-quinolones and zidovudine against some strains of Enterobacteria.
    Mascellino MT; Farinelli S; Iegri F; Iona E
    New Microbiol; 1998 Jan; 21(1):31-40. PubMed ID: 9497927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycosides affect intracellular Salmonella enterica serovars typhimurium and virchow.
    Menashe O; Kaganskaya E; Baasov T; Yaron S
    Antimicrob Agents Chemother; 2008 Mar; 52(3):920-6. PubMed ID: 18172002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
    Chang S; Griesgraber GW; Southern PJ; Wagner CR
    J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine induces the expression of cellular resistance affecting its antiviral activity.
    Dianzani F; Antonelli G; Turriziani O; Riva E; Simeoni E; Signoretti C; Strosselli S; Cianfriglia M
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1471-8. PubMed ID: 7888202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro antibacterial activity of novel 5'-O-analog derivatives of zidovudine as potential prodrugs.
    Moroni GN; Bogdanov PM; Briñón MC
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(3):231-41. PubMed ID: 11991164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages.
    Yang CY; Hsu CY; Fang CS; Shiau CW; Chen CS; Chiu HC
    J Microbiol Immunol Infect; 2019 Aug; 52(4):638-647. PubMed ID: 31239204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5'-aminocarbonyl phosphonates as new zidovudine depot forms: antiviral properties, intracellular transformations, and pharmacokinetic parameters.
    Khandazhinskaya AL; Yanvarev DV; Jasko MV; Shipitsin AV; Khalizev VA; Shram SI; Skoblov YS; Shirokova EA; Kukhanova MK
    Drug Metab Dispos; 2009 Mar; 37(3):494-501. PubMed ID: 19106116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.